All filters
Slidesets
Is HCV drug resistance an issue? (Chinese) | Jürgen Rockstroh, MD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2016
Slidesets
Is HCV drug resistance an issue? (English) | Jürgen Rockstroh, MD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2016
Slidesets
Anti viral hepatitis therapy for patients with liver transplantation (English) | Dr. Jun Li
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2016
Slidesets
Effect of antiviral therapy on liver fibrosis in patients with CHC (English) | Dr. JiDong Jia
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2016
Slidesets
Artificial liver therapy for hepatic failure (Chinese) | Dr. JianHe Gan
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2016
Slidesets
The study of anti HIV/AIDS in Nanjing (Chinese) | Dr. Wei Zhao
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2016
Slidesets
The study of anti HIV/AIDS in Nanjing (English) | Dr. Wei Zhao
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2016
Slidesets
Abstract: Does hepatitis D in HBV/ HIV co-infected patients affect liver function? | J. Kozlowska #1
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015
Slidesets
Abstract: Antioxidant response in patients with chronic hepatitis B or C. | K. Wójcik-Cichy #2
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015
Slidesets
State of the Art Treatment of Hepatitis B | Maria Buti, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015
Slidesets
Abstract: Chronic Hepatitis C Treatment In Patients Coinfected With HCV/HIV | S. Fedorchenko #4
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015
Slidesets
Abstract: Toll-like receptor 4 polymorphism influence on the clinical course of chronic hepatitis C in HIV-infected patients | T. Kyrychenko #5
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015
Slidesets
Acute Hepatitis C Infection | Christoph Boesecke, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015
Slidesets
Abstract: Ledipasvir/sofosbuvir for 12 weeks in patients co-infected with HCV and HIV-1. | S. Mauss #6
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015
Slidesets
Abstract: Endothelial dysfunction and its influence on the development of subclinical atherosclerosis in HIV/HCV positive patients | K. Barska #10
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015
Slidesets
Local Situation in Poland | Milosz Parczewski, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015
Slidesets
AbbVie
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015
Slidesets
Local Situation in Ukraine | Larisa Moroz, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015
Slidesets
Local Situation in Romania | Adrian Streinu Cercel, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015
Slidesets
Local Situation in Baltic Countries | Saulius Caplinskas, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015
Slidesets
Local Situation in Czech and Slovak Republics | Viktor Aster, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015
Slidesets
Local Situation in Turkey | Cihan Yurdaydin, MD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015
Slidesets
Management of End-stage Liver Disease | Massimo Puoti, MD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015